List view / Grid view

Swedish Orphan Biovitrum (SOBI)

 

news

CHMP recommends Elocta for haemophilia A

25 September 2015 | By Victoria White

Elocta is a recombinant factor VIII Fc fusion protein product that, if approved, would be the first haemophilia A treatment with prolonged circulation available in the EU...